Posted by Michael Wonder on 19 Nov 2018
Gottlieb pushes for funding to speed gene therapy reviews
16 November 2018 - The FDA is working to increase its investment in reviewing gene therapy products, Commissioner Scott Gottlieb said Friday.
“We’re getting a hundred [new drug applications] a year for gene therapy products, and we’re going to have to very rapidly grow the size of the group to keep up with the pace of the inbox,” he said at an industry conference.
